-+ 0.00%
-+ 0.00%
-+ 0.00%

Changes in US stocks | Novo Nordisk (NVO.US) rose nearly 6% as rival LLY.US (LLY.US) oral diet pills fell short of expectations

Zhitongcaijing·08/07/2025 14:41:15
Listen to the news

The Zhitong Finance App learned that Novo Nordisk (NVO.US) shares rose higher on Thursday. As of press release, the stock had risen nearly 6% to $47.99. According to the news, Orforglipron, the company's competitor, LLY.US (LLY.US), achieved an average weight loss of 11.2%, falling short of expectations of 13% to 15% or more.